152 related articles for article (PubMed ID: 36333092)
1. Primary central nervous system Hodgkin lymphoma: A case report and review of the literature.
Aliaga D; Mayorga J; Verdú-López F; Gallego JM; Castellá L; Sabater V
Neurocirugia (Astur : Engl Ed); 2022; 33(6):350-355. PubMed ID: 36333092
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration.
Cheah CY; Bröckelmann PJ; Chihara D; Moskowitz AJ; Engert A; Jerkeman M; El-Galaly TC; Augustson B; Vose J; Bartlett NL; Villa D; Connors JM; Feldman T; Pinnix CC; Milgrom SA; Dabaja B; Oki Y; Fanale MA
Am J Hematol; 2016 Sep; 91(9):894-9. PubMed ID: 27222367
[TBL] [Abstract][Full Text] [Related]
3. CNS Hodgkin lymphoma.
Gerstner ER; Abrey LE; Schiff D; Ferreri AJ; Lister A; Montoto S; Tsang R; Thiel E; Graus F; Behringer D; Illerhaus G; Weaver S; Wen P; Voloschin A; Harris NL; Batchelor TT
Blood; 2008 Sep; 112(5):1658-61. PubMed ID: 18591379
[TBL] [Abstract][Full Text] [Related]
4. Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement.
Mociková H; Malikova H; Holesta M; Elturki A; Campr V; Kozak T
Am J Case Rep; 2020 Mar; 21():e921657. PubMed ID: 32170052
[TBL] [Abstract][Full Text] [Related]
5. CNS lymphoma masquerading as stroke: Cases report and literature review.
Liang X; Wang C; Liu Y
J Cell Mol Med; 2023 Dec; 27(23):3939-3947. PubMed ID: 37997520
[TBL] [Abstract][Full Text] [Related]
6. Atypical involvement of central nervous system in classic Hodgkin lymphoma: a case report.
Ahmed S; Irfan B; Raza M; Haider G
J Med Case Rep; 2021 Oct; 15(1):532. PubMed ID: 34711281
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology.
Alfaseh A; Rajeh MN; Hamed G
Avicenna J Med; 2019; 9(1):28-31. PubMed ID: 30697523
[TBL] [Abstract][Full Text] [Related]
8. Primary Hodgkin lymphoma of the central nervous system: two case reports and review of the literature.
Kresak JL; Nguyen J; Wong K; Davis R
Neuropathology; 2013 Dec; 33(6):658-62. PubMed ID: 23530967
[TBL] [Abstract][Full Text] [Related]
9. [Long-term remission after nonmyeloablative allogeneic bone marrow transplantation in a relapsed Hodgkin lymphoma patient with CNS involvement].
Shimura H; Imai Y; Ishiyama M; Yoshinaga K; Shiseki M; Mori N; Teramura M; Motoji T
Rinsho Ketsueki; 2012 Dec; 53(12):1991-6. PubMed ID: 23318964
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Alvarnas JC; Negrin RS; Horning SJ; Hu WW; Long GD; Schriber JR; Stockerl-Goldstein K; Tierney K; Wong R; Blume KG; Chao NJ
Biol Blood Marrow Transplant; 2000; 6(3A):352-8. PubMed ID: 10905773
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system Hodgkin lymphoma: case report and review of the literature.
Torgerson S; Olteanu H; Tinguely M; Fenske TS
J Neurooncol; 2011 Apr; 102(2):329-34. PubMed ID: 20676729
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
Kasamon YL; Jones RJ; Piantadosi S; Ambinder RF; Abrams RA; Borowitz MJ; Morrison C; Smith BD; Flinn IW
Biol Blood Marrow Transplant; 2005 Feb; 11(2):93-100. PubMed ID: 15682069
[TBL] [Abstract][Full Text] [Related]
14. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system Hodgkin's lymphoma: a case report.
Fu H; Shi S; Chen L; Xu B; Huang W; Chen Y; Wu X; Shen J; Liu T
J Int Med Res; 2021 Apr; 49(4):300060521999533. PubMed ID: 33874776
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
Bierman P; Giglio P
Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities in primary CNS lymphoma: A systematic review.
Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.
Chen YB; Batchelor T; Li S; Hochberg E; Brezina M; Jones S; Del Rio C; Curtis M; Ballen KK; Barnes J; Chi AS; Dietrich J; Driscoll J; Gertsner ER; Hochberg F; LaCasce AS; McAfee SL; Spitzer TR; Nayak L; Armand P
Cancer; 2015 Jan; 121(2):226-33. PubMed ID: 25204639
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
[TBL] [Abstract][Full Text] [Related]
20. Can metabolic tumor parameters on primary staging
Okuyucu K; Alagoz E; Ince S; Ozaydin S; Arslan N
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):9-14. PubMed ID: 28733137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
